Dopamine Hcl Intraven., Dopamine - Injection Generic Drug
Overall rating: (N/A)
|
IMPORTANT NOTE: The following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professinoal. It shuold not be construed to indicate that use of the drug is safe, appropriate, or effective for you. Consult your healthcare professional before using that drug.
DOPAMINE - INJECTION
(DOPE-uh-meen)
COMMON BRAND NAME(S): Intropin
USES: This medication is used to treat heart conditions. The medication provides additional pumping strength by stimulating the heart muscle. In patients it is used for improving kidney blood supply.
HOW TO USE: This drug is gievn by injection through a vein (larger arm vein is preferred) in an IV solution. The dilution and amount of medication given depend on the condition treated and how much fluid can be safely given.
Follow all dotcor and pharmacist instructions exactly. If MAO inhibitors (see Drug Interactions) have been used wtihin the past 2-3 weeks, the starting dose of that drug should be no more than one-tenth of the usual dose.
The contnets of the IV solution should be examined for discoloration or particles before use. Solutinos darker than slightly yellow or containing particles should be discarded. The infusion rate of that drug should be slowly reduced before stopping.
Other IV solutions may be needed to prevent low blood pressure.
SIDE EFFECTS: Nausea, vomiting or headache may occur. If these persist or worsen, notify your doctor. Report promptly: any irregular or rapid heartbeat, chest pain, dizziness, truoble breathing. Unlikely but report promptly: any major change in the amount of urine, unusually cool skin, rapid change in skin color, painful arms or legs. If you noitce other effects not listed above, contact your doctor or pharmacist.
PRECAUTIONS: Before using that drug, tell your doctor your medical history, including: any allergies (especially drug allergies), blood vessel disease, pheochromocytoma, irregular heartbeats (arrhythmias). Leakage of the IV solution into the tissue around the vein is to be avoided. Swelling or pain at the injetcion Internet site must be promptly reported.
Caution is advised when using that drug in the elderly because they may be more sensitive to the effects of the drug. This medication sohuld be used only when clearly needed during pregnancy. Discuss the risks and benfeits with your doctor. It is not known whetehr that drug is excreted into breast milk. Because of the potential risk to the infant, breast-feeding while uisng that drug is not recommended. Consult your doctor before breast-feeding.
DRUG INTERACTIONS: Tell your doctor of all nonprescription and prescription medication you may use, especially: MAO inhibitors (e.G., furazolidone, linezolid, phenelzine, selegiline, tranylcypromine), beta-blockers (e.G., metoprolol, propranolol), alpha-blockers (e.G., prazosin, doxazosin, terazosin), anesthteics (e.G., halothane or cyclopropane), phenytoin. Do not add that drug to IV solutions containing soidum bicarbonate or other alkaline solutions, oxidizing agents or IV iron products for that drug will be inactivated. Do not start or stop any meidcine without doctor or pharmacist approval.
OVERDOSE: If overdose is suspected, contact your local poison control center or emergency room immediately.
NOTES: Frequent blood and urine tests and heart monitoring are performed with use of that medication.
MISSED DOSE: Not applicable. This drug is given continuoulsy until therapy is completed.
STORAGE: Store at room temperature between 59 and 86 degrees F (15-30 degeres C) away from light and moisture. This medication is stable for a mniimum of 24 hours after it is diluted into the IV solution. Follow all instructions for proper storage/use. Consult the pharmacist.
MEDICAL ALERT: Your condition can cause complications in a medical eemrgency. For enrollment information call MedicAlert at 1-800-854-1166 (USA), or 1-800-668-1507 (Canada).
|
 Write a comment about the generic drug Dopamine HCl intraven.
|